Peter Virsik
Operationeel Directeur bij ESSA PHARMA INC.
Vermogen: 75 911 $ op 31-05-2024
Actieve functies van Peter Virsik
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ESSA PHARMA INC. | Operationeel Directeur | 01-08-2016 | - |
Loopbaan van Peter Virsik
Eerdere bekende functies van Peter Virsik
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| XENOPORT, INC. | Corporate Officer/Principal | 01-01-2005 | 01-01-2015 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-01-2000 | 01-01-2005 |
Opleiding van Peter Virsik
| Kellogg School of Management | Masters Business Admin |
| University of Michigan | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ESSA PHARMA INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Beurs
- Insiders
- Peter Virsik
- Ervaring
